Overview

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of S-309309 in Healthy and Obese Participants

Status:
Recruiting

Trial end date:
2022-10-20

Target enrollment:

Participant gender:

Summary

The primary aim of the study is to assess the safety and tolerability of S-309309 after oral administration in healthy adult or obese but otherwise healthy adult participants. The secondary aim of the study is to assess the pharmacokinetics of S-309309 and the effects on ECG parameters after oral administration in healthy or obese but otherwise healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Shionogi

Treatments:

Midazolam